Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FL3LA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,414
Award facts
- Contract value 100% obligated
- $35,414.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $35,414.05 delivery order to Amerisourcebergen Drug Corp on June 30, 2026, for Dupixent 300 mg/2 ml pen injectables with an ultimate completion date of July 1, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FL3LA?
SPE2DR26FL3LA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 30, 2026.
How much is contract SPE2DR26FL3LA worth?
The government has obligated $35,414 on SPE2DR26FL3LA.
Is contract SPE2DR26FL3LA an order under another contract?
Yes. SPE2DR26FL3LA is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL3LA competed?
The extent of competition for SPE2DR26FL3LA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award